OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer - a ctDNA-guided phase II randomised approach. Study protocol

Authors :: Louise Bach Callesen
Torben Frøstrup Hansen
Rikke Fredslund Andersen
Niels Pallisgaard
Stine Kramer
Sven Schlander
Søren Rafael Rafaelsen
Anders Kindberg Boysen
Lars Henrik Jensen
Anders Jakobsen
Karen-Lise Garm Spindler
Source :: Callesen, L B, Hansen, T F, Andersen, R F, Pallisgaard, N, Kramer, S M J, Schlander, S, Rafaelsen, S R, Boysen, A K, Jensen, L H, Jakobsen, A & Spindler, K-L G 2022, ' OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer-a ctDNA-guided phase II randomised approach. Study protocol ', Acta Oncologica, vol. 61, no. 9, pp. 1152-1156 . https://doi.org/10.1080/0284186X.2022.2116728
Publication Year :: 2022

Subjects :: Clinical Trials, Phase II as Topic
Oncology
Patient Selection
Humans
Radiology, Nuclear Medicine and imaging
Hematology
General Medicine
Colorectal Neoplasms
Follow-Up Studies
Circulating Tumor DNA

Language :: English
Database :: OpenAIRE
Journal :: Callesen, L B, Hansen, T F, Andersen, R F, Pallisgaard, N, Kramer, S M J, Schlander, S, Rafaelsen, S R, Boysen, A K, Jensen, L H, Jakobsen, A & Spindler, K-L G 2022, ' OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer-a ctDNA-guided phase II randomised approach. Study protocol ', Acta Oncologica, vol. 61, no. 9, pp. 1152-1156 . https://doi.org/10.1080/0284186X.2022.2116728
Accession number :: edsair.doi.dedup.....ae20288c3b782eb4b15788911e6a05fe
Full Text :: https://doi.org/10.1080/0284186X.2022.2116728

Full Text Access

Tools